U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 24-30, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 24-30, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 10/25/2021
Location: Virtual
Subject: Forum for Collaboration Research: Retinal Diseases
FDA Participant/Group: KIMBERLY RAWLINGS;
Non FDA Participant/Group: Veronica Miller (University of California, Berkeley School of Public Health);

Event Date: 10/26/2021
Location: Virtual
Subject: Pharmaceutical Quality Symposium 2021: Innovations in a Changing World; Keynote Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, and other registered participants

Event Date: 10/26/2021
Location: Virtual
Subject: Massachusetts Institute of Technology (MIT) and Continuous Manufacturing and Crystallisation Consortium Meeting; Progress on the Implementation of Pharmaceutical Continuous Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Clive Badman (University of Strathclyde); Moheb Nasr (Nasr Pharma Regulatory Consulting); Bernhardt Trout (Continuus Pharmaceutical);

Event Date: 10/26/2021
Location: Virtual
Subject: Cybersecurity Summit for Private Industry Partners in Food and Agriculture
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 10/26/2021
Location: Virtual
Subject: Intergovernmental Working Meeting on Drug Compounding
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 10/27/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 10/27/2021
Location: Virtual
Subject: Generic Drug User Fee Act (GDUFA) III
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from industry and congressional staff

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/26/2021
Location: Virtual
Subject: China International Food Safety & Quality Conference 2021; Keynote: New Era of Smarter Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Regulators, scientists, industry executives, technologists, and academics

Event Date: 10/26/2021
Location: Virtual
Subject: Maple Leaf Foods 2021 Food Safety Symposium; Moderator: Food Safety Culture
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and government

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 10/26/2021
Location: Virtual
Subject: 10th Meeting of the Member State Mechanism on Substandard and Falsified Medical Products
FDA Participant/Group: RUSSELL CAMPBELL, LEIGH VERBOIS
Non FDA Participant/Group: World Health Organization (WHO) Member State Participants

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 10/26/2021
Location: Virtual
Subject: Partnership for Food Protection Meeting; Opening Statements
FDA Participant/Group: DOUGLAS STEARN; MICHAEL ROGERS; TRACEY FORFA; BARBARA CASSENS; JUDITH MCMEEKIN; JEFFREY FARRAR; ABRAM BROWN;
Non FDA Participant/Group: Representatives from industry and government

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/25/2021
Location: Virtual
Subject: NIH / NIAID Workshop: Leveraging the COVID Vaccine Experience to Accelerate the Development of a Safe and Efficacious HIV Vaccine; Lessons from COVID That Can Be Applied Towards HIV Moving Forward
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry and academia

Event Date: 10/27/2021
Location: Virtual
Subject: Politico Live Health Care Summit 2021; Panelist: Redefining the Speed of Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, patient advocacy, government, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/26/2021
Location: Virtual
Subject: Clinical Studies
FDA Participant/Group: FELIPE AGUEL; CHANGFU WU; DANIEL CANOS; NICOLE GILLETTE; BRAM ZUCKERMAN; NICOLE IBRAHIM; MEIR SHINNAR; WILLIAM MAISEL;
Non FDA Participant/Group: Dave Weber, Chuck Simonton and Mike Minogue (AbioMed);

Event Date: 10/28/2021
Location: Virtual
Subject: Impella Heart Pump Data Generation and Randomized Trials
FDA Participant/Group: WILLIAM MAISEL; MEIR SHINNAR; CHANGFU WU; NICOLE GILLETTE; BRAM ZUCKERMAN;
Non FDA Participant/Group: Daniel Burkhoff (Columbia University); Navin Kapur (Tufts Medical Center); William O’Neill (Henry Ford Health System); Gregg Stone (Cardiovascular Research Foundation );

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 10/26/2021
Location: Virtual
Subject: Food Labeling Meeting
FDA Participant/Group: EMILY ROSE CAREY; STEFANO LUCCIOLI; CLAUDINE KAVANAUGH; PATRICIA HANSEN; JENNIFER DOOREN;
Non FDA Participant/Group: Beth Johnson, Lisa Gable, Robert Earl (Food Allergy Research and Education (FARE));

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 10/27/2021
Location: Virtual
Subject: Food and Drug Law Institute (FDLI) Tobacco Conference; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, academia, government, and other stakeholders

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top